- Training
- October 2026
- 2 Days
Global
€1805EUR$2,097USD£1,499GBP
- Report
- June 2026
- 202 Pages
Global
From €4142EUR$4,650USD£3,561GBP
- Report
- May 2026
- 140 Pages
Global
From €4320EUR$4,850USD£3,714GBP
- Report
- October 2025
- 87 Pages
Global
From €4008EUR$4,500USD£3,446GBP
- Report
- March 2026
- 248 Pages
United States
From €4320EUR$4,850USD£3,714GBP
- Report
- September 2026
- 381 Pages
Global
From €5211EUR$5,850USD£4,479GBP
- Report
- June 2026
- 200 Pages
Global
From €2663EUR$2,990USD£2,289GBP
- Report
- August 2026
- 192 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 196 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 190 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 194 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 188 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- August 2026
- 184 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 182 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 195 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 180 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- January 2026
- 197 Pages
Global
From €3158EUR$3,545USD£2,714GBP
€3509EUR$3,939USD£3,016GBP
- Report
- February 2026
- 200 Pages
Global
From €2663EUR$2,990USD£2,289GBP
- Report
- February 2026
- 150 Pages
Global
From €5300EUR$5,950USD£4,556GBP
- Report
- October 2025
- 250 Pages
Global
From €5300EUR$5,950USD£4,556GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more